Plasma cell neoplasms including multiple myeloma (MM) and related terminally
differentiated B-cell neoplasms are characterized by secretion of monoclonal …

Recent insight in the genomic landscape of newly diagnosed multiple myeloma (NDMM)
and its precursor conditions, monoclonal gammopathy of uncertain significance (MGUS) …

Mitochondrial damage–associated molecular patterns (mtDAMPs) include proteins, lipids,
metabolites, and DNA and have various context-specific immunoregulatory functions. Cell …

Multiple myeloma (MM) is a clonal bone marrow disorder of plasma cells. MM is preceded
by the precursor conditions monoclonal gammopathy of undetermined significance (MGUS) …

This study aimed to provide real-world evidence on progression risk in patients with high-
risk smoldering multiple myeloma (SMM). This retrospective, observational study leveraged …

Introduction: Multiple myeloma (MM) is a highly heterogeneous hematologic malignancy.
The patients' survival outcomes vary widely. Establishing a more accurate prognostic model …

The plasma cell cancer multiple myeloma (MM) varies significantly in genomic
characteristics, response to therapy, and long-term prognosis. To investigate global …

Smoldering multiple myeloma (SMM) is an asymptomatic plasma cell (PC) neoplasm that
may evolve with variable frequency into multiple myeloma (MM). SMM is initiated by …

The genomic landscape of Waldenström macroglobulinemia (WM) is characterized by
somatic mutations in MYD88, present from the precursor stages. Using the comprehensive …

Smoldering multiple myeloma (MM) is an asymptomatic clonal plasma cell condition
considered as a premalignant entity that may evolve over time to symptomatic MM. Based on …